Richa Vartak
- Molecular Biology
- Oncology
- Pharmaceutical Science top 5%
- Infectious Diseases
- Pulmonary and Respiratory Medicine
- Co-authors
- Ketan PatelAishwarya SaraswatManali PatkiBlasé BillackRehab HegazySuyash M. PatilNitesh K. KundaYige Fu
- Topics
- Protein Degradation and Inhibitors (5 papers)Antifungal resistance and susceptibility (3 papers)Peptidase Inhibition and Analysis (3 papers)
- Partner nations
- United StatesEgyptPoland
In The Last Decade
Richa Vartak
21 papers receiving 361 citations
Peers
Comparison fields: 5 of 83
- Molecular Biology 170
- Oncology 81
- Pharmaceutical Science 76
- Infectious Diseases 55
- Pulmonary and Respiratory Medicine 42
Countries citing papers authored by Richa Vartak
This map shows the geographic impact of Richa Vartak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richa Vartak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richa Vartak more than expected).
Fields of papers citing papers by Richa Vartak
This network shows the impact of papers produced by Richa Vartak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richa Vartak. The network helps show where Richa Vartak may publish in the future.
Co-authorship network of co-authors of Richa Vartak
This figure shows the co-authorship network connecting the top 25 collaborators of Richa Vartak. A scholar is included among the top collaborators of Richa Vartak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richa Vartak. Richa Vartak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 10 | |
| 5 | 0 | |
| 6 | 6 | |
| 7 | 20 | |
| 8 | 19 | |
| 9 | 51 | |
| 10 | 28 | |
| 11 | 5 | |
| 12 | 63 | |
| 13 | 5 | |
| 14 | 15 | |
| 15 | 11 | |
| 16 | 25 | |
| 17 | 15 | |
| 18 | 58 | |
| 19 | 8 | |
| 20 | 11 |
About Richa Vartak
Richa Vartak is a scholar working on Toxicology, Dermatology and Pharmaceutical Science, having authored 22 papers that have together received 366 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (5 papers), Antifungal resistance and susceptibility (3 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Pharmaceutical Science (76 citations), Toxicology (29 citations) and Infectious Diseases (55 citations). Richa Vartak has collaborated with scholars based in United States, Egypt and Poland. Frequent co-authors include Ketan Patel, Aishwarya Saraswat, Manali Patki, Blasé Billack, Rehab Hegazy, Suyash M. Patil, Nitesh K. Kunda, Yige Fu, Yuqi Yang and Zhe‐Sheng Chen. Their work appears in journals such as Journal of Controlled Release, Molecules and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.